Skip to main content

Madison biotech Third Wave to be bought for $580 million

Third Wave Technologies is expected to stay in Madison even though a Massachusetts medical diagnostics company plans to buy the company, experts say.

Hologic, a Bedford, Mass., company with sales last year of $738 million and more than 3,500 employees, said Monday it will buy Third Wave for $580 million cash, or $11.25 a share. Third Wave will become a Hologic subsidiary.

“The combination of Hologic and Third Wave brings together two great companies that employ complementary technologies but share a common mission: to help save the lives of women,” said Jack Cumming, chairman and chief executive of Hologic, in a written statement.